322 related articles for article (PubMed ID: 31704359)
21. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
[TBL] [Abstract][Full Text] [Related]
22. Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort.
Odia Y; Hall MD; Cloughesy TF; Wen PY; Arrillaga-Romany I; Daghistani D; Mehta MP; Tarapore RS; Ramage SC; Allen JE
Neuro Oncol; 2024 May; 26(Supplement_2):S165-S172. PubMed ID: 38386699
[TBL] [Abstract][Full Text] [Related]
23. Pediatric thalamic glioma with H3F3A K27M mutation, which was detected before and after malignant transformation: a case report.
Ishibashi K; Inoue T; Fukushima H; Watanabe Y; Iwai Y; Sakamoto H; Yamasaki K; Hara J; Shofuda T; Kanematsu D; Yoshioka E; Kanemura Y
Childs Nerv Syst; 2016 Dec; 32(12):2433-2438. PubMed ID: 27392443
[TBL] [Abstract][Full Text] [Related]
24. Diffuse Midline Gliomas With Histone H3 K27M Mutation in Adults and Children: A Retrospective Series of 164 Cases.
Zheng L; Gong J; Yu T; Zou Y; Zhang M; Nie L; Chen X; Yue Q; Liu Y; Mao Q; Zhou Q; Chen N
Am J Surg Pathol; 2022 Jun; 46(6):863-871. PubMed ID: 35416795
[TBL] [Abstract][Full Text] [Related]
25. A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations.
Nakano Y; Yamasaki K; Sakamoto H; Matsusaka Y; Kunihiro N; Fukushima H; Inoue T; Honda-Kitahara M; Hara J; Yoshida A; Ichimura K
Brain Tumor Pathol; 2019 Oct; 36(4):162-168. PubMed ID: 31254135
[TBL] [Abstract][Full Text] [Related]
26. Lateral or Medial Surgical Approaches for Thalamic Gliomas Resection?
Qinglong G; Wei H; Biwu W; Zhiqi L; Yikui L; Pin S; Dongxiao Z; Tianming Q; Yi Z
World Neurosurg; 2020 Apr; 136():e90-e107. PubMed ID: 31785434
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of pediatric glioma outcomes using intraoperative MRI: a multicenter cohort study.
Karsy M; Akbari SH; Limbrick D; Leuthardt EC; Evans J; Smyth MD; Strahle J; Leonard J; Cheshier S; Brockmeyer DL; Bollo RJ; Kestle JR; Honeycutt J; Donahue DJ; Roberts RA; Hansen DR; Riva-Cambrin J; Sutherland G; Gallagher C; Hader W; Starreveld Y; Hamilton M; Duhaime AC; Jensen RL; Chicoine MR
J Neurooncol; 2019 Jun; 143(2):271-280. PubMed ID: 30977059
[TBL] [Abstract][Full Text] [Related]
28. MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial.
Rodriguez D; Calmon R; Aliaga ES; Warren D; Warmuth-Metz M; Jones C; Mackay A; Varlet P; Le Deley MC; Hargrave D; Cañete A; Massimino M; Azizi AA; Saran F; Zahlmann G; Garcia J; Vassal G; Grill J; Peet A; Dineen RA; Morgan PS; Jaspan T
Radiology; 2022 Jul; 304(1):174-182. PubMed ID: 35412366
[TBL] [Abstract][Full Text] [Related]
29. A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal glioma.
Akinduro OO; Garcia DP; Higgins DMO; Vivas-Buitrago T; Jentoft M; Solomon DA; Daniels DJ; Pennington Z; Sherman WJ; Delgardo M; Bydon M; Kalani MA; Zanazzi G; Tsankova N; Bendok BR; McCormick PC; Sciubba DM; Lo SL; Clarke JL; Abode-Iyamah K; Quiñones-Hinojosa A
J Neurosurg Spine; 2021 Aug; 35(6):834-843. PubMed ID: 34416733
[TBL] [Abstract][Full Text] [Related]
30. Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.
Dono A; Takayasu T; Ballester LY; Esquenazi Y
J Clin Neurosci; 2020 Dec; 82(Pt A):1-8. PubMed ID: 33317715
[TBL] [Abstract][Full Text] [Related]
31. Significance of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of Cerebral Hemispheres.
La Rocca G; Sabatino G; Altieri R; Signorelli F; Ricciardi L; Gessi M; Della Pepa GM
World Neurosurg; 2019 Nov; 131():174-176. PubMed ID: 31415896
[TBL] [Abstract][Full Text] [Related]
32. Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System.
Yi S; Choi S; Shin DA; Kim DS; Choi J; Ha Y; Kim KN; Suh CO; Chang JH; Kim SH; Yoon DH
Neurosurgery; 2019 May; 84(5):1072-1081. PubMed ID: 29718432
[TBL] [Abstract][Full Text] [Related]
33. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
[TBL] [Abstract][Full Text] [Related]
34. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
[TBL] [Abstract][Full Text] [Related]
35. Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial.
Rodriguez Gutierrez D; Jones C; Varlet P; Mackay A; Warren D; Warmuth-Metz M; Aliaga ES; Calmon R; Hargrave DR; Cañete A; Massimino M; Azizi AA; Le Deley MC; Saran F; Rousseau RF; Zahlmann G; Garcia J; Vassal G; Grill J; Morgan PS; Jaspan T
Clin Cancer Res; 2020 Apr; 26(8):1856-1865. PubMed ID: 31924736
[TBL] [Abstract][Full Text] [Related]
36. Optimizing Postoperative Surveillance of Pediatric Low-Grade Glioma Using Tumor Behavior Patterns.
Zaazoue MA; Manley PE; Mehdar MA; Ullrich NJ; Dasenbrock HH; Chordas CA; Goumnerova LC
Neurosurgery; 2020 Feb; 86(2):288-297. PubMed ID: 30892635
[TBL] [Abstract][Full Text] [Related]
37. Distant recurrences limit the survival of patients with thalamic high-grade gliomas after successful resection.
Saito R; Kumabe T; Kanamori M; Sonoda Y; Tominaga T
Neurosurg Rev; 2017 Jul; 40(3):469-477. PubMed ID: 27987035
[TBL] [Abstract][Full Text] [Related]
38. H3 G34-mutant high-grade glioma.
Lim KY; Won JK; Park CK; Kim SK; Choi SH; Kim T; Yun H; Park SH
Brain Tumor Pathol; 2021 Jan; 38(1):4-13. PubMed ID: 32995948
[TBL] [Abstract][Full Text] [Related]
39. High-grade thalamic gliomas: Microsurgical treatment and prognosis analysis.
Wu B; Tang C; Wang Y; Li Z; Hu S; Hua W; Li W; Huang S; Ma J; Zhang Y
J Clin Neurosci; 2018 Mar; 49():56-61. PubMed ID: 29248381
[TBL] [Abstract][Full Text] [Related]
40. Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging.
Jung JS; Choi YS; Ahn SS; Yi S; Kim SH; Lee SK
Neuroradiology; 2019 Mar; 61(3):313-322. PubMed ID: 30662997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
